AAAAAA

   
Results: 1-25 | 26-50 | 51-55
Results: 1-25/55
H-2 NMR INVESTIGATIONS OF THE HEXADECANE UREA INCLUSION COMPOUND/
Authors: SCHMIDER J MULLER K
Citation: J. Schmider et K. Muller, H-2 NMR INVESTIGATIONS OF THE HEXADECANE UREA INCLUSION COMPOUND/, The journal of physical chemistry. A, Molecules, spectroscopy, kinetics, environment, & general theory, 102(7), 1998, pp. 1181-1193
CLOZAPINE IN TOURETTES-SYNDROME
Authors: SCHMIDER J HOFF P
Citation: J. Schmider et P. Hoff, CLOZAPINE IN TOURETTES-SYNDROME, Journal of clinical psychopharmacology, 18(1), 1998, pp. 88-89
ENDURANCE TRAINING AND ITS EFFECT UPON THE ACTIVITY OF THE GH-IGFS SYSTEM IN THE ELDERLY
Authors: DEUSCHLE M BLUM WF FRYSTYK J ORSKOV H SCHWEIGER U WEBER B KORNER A GOTTHARDT U SCHMIDER J STANDHARDT H HEUSER I
Citation: M. Deuschle et al., ENDURANCE TRAINING AND ITS EFFECT UPON THE ACTIVITY OF THE GH-IGFS SYSTEM IN THE ELDERLY, International journal of sports medicine, 19(4), 1998, pp. 250-254
HERITABLE POLYMORPHISMS IN THE DOPAMINE AND SEROTONIN RECEPTORS IN SCHIZOPHRENIC-PATIENTS AND HEALTHY CONTROLS
Authors: KAISER R BROCKMOLLER J SCHMIDER J ROOTS I
Citation: R. Kaiser et al., HERITABLE POLYMORPHISMS IN THE DOPAMINE AND SEROTONIN RECEPTORS IN SCHIZOPHRENIC-PATIENTS AND HEALTHY CONTROLS, American journal of medical genetics, 81(6), 1998, pp. 518-519
5 DISTINCT HUMAN CYTOCHROMES MEDIATE AMITRIPTYLINE N-DEMETHYLATION IN-VITRO - DOMINANCE OF CYP 2C19 AND 3A4
Authors: VENKATAKRISHNAN K GREENBLATT DJ VONMOLTKE LL SCHMIDER J HARMATZ JS SHADER RI
Citation: K. Venkatakrishnan et al., 5 DISTINCT HUMAN CYTOCHROMES MEDIATE AMITRIPTYLINE N-DEMETHYLATION IN-VITRO - DOMINANCE OF CYP 2C19 AND 3A4, Journal of clinical pharmacology, 38(2), 1998, pp. 112-121
METABOLISM OF ANTIPSYCHOTICS AND CYP2D6 GENOTYPE
Authors: SCHMIDER J WALTER S SACHSE C BAUER S MULLEROERLINGHAUSEN B ROOTS I BROCKMOLLER J
Citation: J. Schmider et al., METABOLISM OF ANTIPSYCHOTICS AND CYP2D6 GENOTYPE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4716-4716
THE CYP2D6 POLYMORPHISM PARTIALLY EXPLAINS THE HIGH VARIABILITY OF THE SERUM CONCENTRATIONS OF PERAZINE
Authors: BROCKMOLLER J SCHMIDER J SACHSE C FILLER D MULLEROERLINGHAUSEN B ROOTS I
Citation: J. Brockmoller et al., THE CYP2D6 POLYMORPHISM PARTIALLY EXPLAINS THE HIGH VARIABILITY OF THE SERUM CONCENTRATIONS OF PERAZINE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4723-4723
METABOLIC GENOTYPE OF SCHIZOPHRENIC-PATIENTS AND HALOPERIDOL METABOLISM
Authors: SCHMIDER J SACHSE C WALTER S FILLER D KAISER R ROOTS I BROCKMOLLER J
Citation: J. Schmider et al., METABOLIC GENOTYPE OF SCHIZOPHRENIC-PATIENTS AND HALOPERIDOL METABOLISM, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 636-636
CYTOCHROME-P450 2D6 GENOTYPE PARTIALLY EXPLAINS INTERINDIVIDUAL PHARMACOKINETIC VARIABILITY OF PERAZINE AND DESMETHYLPERAZINE
Authors: BROCKMOLLER J SCHMIDER J SACHSE C SCHLEY J MULLEROERLINGHAUSEN B ROOTS I
Citation: J. Brockmoller et al., CYTOCHROME-P450 2D6 GENOTYPE PARTIALLY EXPLAINS INTERINDIVIDUAL PHARMACOKINETIC VARIABILITY OF PERAZINE AND DESMETHYLPERAZINE, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 637-637
PSYCHOGENIC CATATONIA - RESPONSE TO LORAZEPAM AND OXAZEPAM
Authors: SCHMIDER J STANDHART H DEUSCHLE M DRANCOLI J HEUSER I
Citation: J. Schmider et al., PSYCHOGENIC CATATONIA - RESPONSE TO LORAZEPAM AND OXAZEPAM, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 50-50
CYP2D6 GENOTYPE IN PSYCHIATRIC-PATIENTS - IMPACT ON HALOPERIDOL METABOLISM
Authors: SCHMIDER J SACHSE C WALTER S FILLER D KAISER R ROOTS I BROCKMOLLER J
Citation: J. Schmider et al., CYP2D6 GENOTYPE IN PSYCHIATRIC-PATIENTS - IMPACT ON HALOPERIDOL METABOLISM, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 51-51
REEVALUATION OF THE SPECIFICITY OF DEXTROMETHORPHAN AS AN INDEX SUBSTRATE
Authors: VONMOLTKE LL GREENBLATT DJ GRASSI JG GRANDA BW SCHMIDER J HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., REEVALUATION OF THE SPECIFICITY OF DEXTROMETHORPHAN AS AN INDEX SUBSTRATE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 80-80
THE COMBINED DEXAMETHASONE CORTICOTROPIN-RELEASING HORMONE STIMULATION TEST IS MORE CLOSELY ASSOCIATED WITH FEATURES OF DIURNAL ACTIVITY OFTHE HYPOTHALAMO-PITUITARY-ADRENOCORTICAL SYSTEM THAN THE DEXAMETHASONE SUPPRESSION TEST/
Authors: DEUSCHLE M SCHWEIGER U GOTTHARDT U WEBER B KORNER A SCHMIDER J STANDHARDT H LAMMERS CH KRUMM B HEUSER I
Citation: M. Deuschle et al., THE COMBINED DEXAMETHASONE CORTICOTROPIN-RELEASING HORMONE STIMULATION TEST IS MORE CLOSELY ASSOCIATED WITH FEATURES OF DIURNAL ACTIVITY OFTHE HYPOTHALAMO-PITUITARY-ADRENOCORTICAL SYSTEM THAN THE DEXAMETHASONE SUPPRESSION TEST/, Biological psychiatry, 43(10), 1998, pp. 762-766
IN-VITRO APPROACHES TO PREDICTING DRUG-INTERACTIONS IN-VIVO
Authors: VONMOLTKE LL GREENBLATT DJ SCHMIDER J WRIGHT CE HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., IN-VITRO APPROACHES TO PREDICTING DRUG-INTERACTIONS IN-VIVO, Biochemical pharmacology, 55(2), 1998, pp. 113-122
HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO
Authors: VONMOLTKE LL GREENBLATT DJ DUAN SX SCHMIDER J WRIGHT CE HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO, Psychopharmacology, 132(4), 1997, pp. 402-407
INHIBITION OF CYP2C9 BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN-VITRO - STUDIES OF PHENYTOIN P-HYDROXYLATION
Authors: SCHMIDER J GREENBLATT DJ VONMOLTKE LL KARSOV D SHADER RI
Citation: J. Schmider et al., INHIBITION OF CYP2C9 BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN-VITRO - STUDIES OF PHENYTOIN P-HYDROXYLATION, British journal of clinical pharmacology, 44(5), 1997, pp. 495-498
INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) PLASMA-CONCENTRATIONS ARE INCREASED IN DEPRESSED-PATIENTS
Authors: DEUSCHLE M BLUM WF STRASBURGER CJ SCHWEIGER U WEBER B KORNER A STANDHARDT H GOTTHARDT U SCHMIDER J PFLAUM CD HEUSER I
Citation: M. Deuschle et al., INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) PLASMA-CONCENTRATIONS ARE INCREASED IN DEPRESSED-PATIENTS, Psychoneuroendocrinology, 22(7), 1997, pp. 493-503
PULSE-DOSING AND CONVENTIONAL APPLICATION OF DOXEPIN - EFFECTS ON PSYCHOPATHOLOGY AND HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) SYSTEM
Authors: DEUSCHLE M SCHMIDER J WEBER B STANDHARDT H KORNER A LAMMERS CH SCHWEIGER U HARTMANN A HEUSER I
Citation: M. Deuschle et al., PULSE-DOSING AND CONVENTIONAL APPLICATION OF DOXEPIN - EFFECTS ON PSYCHOPATHOLOGY AND HYPOTHALAMUS-PITUITARY-ADRENAL (HPA) SYSTEM, Journal of clinical psychopharmacology, 17(3), 1997, pp. 156-160
METABOLISM OF DEXTROMETHORPHAN IN-VITRO - INVOLVEMENT OF CYTOCHROMES P450 2D6 AND 3A3 4, WITH A POSSIBLE ROLE OF 2E1/
Authors: SCHMIDER J GREENBLATT DJ FOGELMAN SM VONMOLTKE LL SHADER RI
Citation: J. Schmider et al., METABOLISM OF DEXTROMETHORPHAN IN-VITRO - INVOLVEMENT OF CYTOCHROMES P450 2D6 AND 3A3 4, WITH A POSSIBLE ROLE OF 2E1/, Biopharmaceutics & drug disposition, 18(3), 1997, pp. 227-240
BIOTRANSFORMATION OF MESTRANOL TO ETHINYL ESTRADIOL IN-VITRO - THE ROLE OF CYTOCHROME-P-450 2C9 AND METABOLIC-INHIBITORS
Authors: SCHMIDER J GREENBLATT DJ VONMOLTKE LL KARSOV D VENA R FRIEDMAN HL SHADER RI
Citation: J. Schmider et al., BIOTRANSFORMATION OF MESTRANOL TO ETHINYL ESTRADIOL IN-VITRO - THE ROLE OF CYTOCHROME-P-450 2C9 AND METABOLIC-INHIBITORS, Journal of clinical pharmacology, 37(3), 1997, pp. 193-200
WITH AGING IN HUMANS THE ACTIVITY OF THE HYPOTHALAMUS-PITUITARY-ADRENAL SYSTEM INCREASES AND ITS DIURNAL AMPLITUDE FLATTENS
Authors: DEUSCHLE M GOTTHARDT U SCHWEIGER U WEBER B KORNER A SCHMIDER J STANDHARDT H LAMMERS CH HEUSER I
Citation: M. Deuschle et al., WITH AGING IN HUMANS THE ACTIVITY OF THE HYPOTHALAMUS-PITUITARY-ADRENAL SYSTEM INCREASES AND ITS DIURNAL AMPLITUDE FLATTENS, Life sciences, 61(22), 1997, pp. 2239-2246
DIURNAL ACTIVITY AND PULSATILITY OF THE HYPOTHALAMUS-PITUITARY-ADRENAL SYSTEM IN MALE DEPRESSED PATIENTS AND HEALTHY CONTROLS
Authors: DEUSCHLE M SCHWEIGER U WEBER B GOTTHARDT U KORNER A SCHMIDER J STANHARDT E LAMMERS CH HEUSER I
Citation: M. Deuschle et al., DIURNAL ACTIVITY AND PULSATILITY OF THE HYPOTHALAMUS-PITUITARY-ADRENAL SYSTEM IN MALE DEPRESSED PATIENTS AND HEALTHY CONTROLS, The Journal of clinical endocrinology and metabolism, 82(1), 1997, pp. 234-238
HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO
Authors: VONMOLTKE LL GREENBLATT DJ DUAN SX SCHMIDER J HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., HUMAN CYTOCHROMES MEDIATING N-DEMETHYLATION OF FLUOXETINE IN-VITRO, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 48-48
INHIBITION OF VENLAFAXINE METABOLISM IN-VITRO BY INDEX INHIBITORS ANDBY SSRI ANTIDEPRESSANTS
Authors: FOGELMAN S SCHMIDER J GREENBLATT DJ SHADER RI
Citation: S. Fogelman et al., INHIBITION OF VENLAFAXINE METABOLISM IN-VITRO BY INDEX INHIBITORS ANDBY SSRI ANTIDEPRESSANTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 66-66
VENLAFAXINE AND METABOLITES ARE VERY WEAK INHIBITORS OF HUMAN CYTOCHROME P450-3A ISOFORMS
Authors: VONMOLTKE LL DUAN SX GREENBLATT DJ FOGELMAN SM SCHMIDER J HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., VENLAFAXINE AND METABOLITES ARE VERY WEAK INHIBITORS OF HUMAN CYTOCHROME P450-3A ISOFORMS, Biological psychiatry, 41(3), 1997, pp. 377-380
Risultati: 1-25 | 26-50 | 51-55